These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Modulation of the fate of zein nanoparticles by their coating with a Gantrez® AN-thiamine polymer conjugate. Inchaurraga L; Martínez-López AL; Abdulkarim M; Gumbleton M; Quincoces G; Peñuelas I; Martin-Arbella N; Irache JM Int J Pharm X; 2019 Dec; 1():100006. PubMed ID: 31517271 [TBL] [Abstract][Full Text] [Related]
4. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration. Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441 [TBL] [Abstract][Full Text] [Related]
6. Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans. Martínez-López AL; González-Navarro CJ; Vizmanos JL; Irache JM Drug Deliv Transl Res; 2021 Apr; 11(2):647-658. PubMed ID: 33515186 [TBL] [Abstract][Full Text] [Related]
7. The effect of thiamine-coating nanoparticles on their biodistribution and fate following oral administration. Inchaurraga L; Martínez-López AL; Cattoz B; Griffiths PC; Wilcox M; Pearson JP; Quincoces G; Peñuelas I; Martin-Arbella N; Irache JM Eur J Pharm Sci; 2019 Feb; 128():81-90. PubMed ID: 30472222 [TBL] [Abstract][Full Text] [Related]
8. Food Protein Based Core-Shell Nanocarriers for Oral Drug Delivery: Effect of Shell Composition on in Vitro and in Vivo Functional Performance of Zein Nanocarriers. Alqahtani MS; Islam MS; Podaralla S; Kaushik RS; Reineke J; Woyengo T; Perumal O Mol Pharm; 2017 Mar; 14(3):757-769. PubMed ID: 28103046 [TBL] [Abstract][Full Text] [Related]
9. Zein-based nanoparticles for the oral delivery of insulin. Inchaurraga L; Martínez-López AL; Martin-Arbella N; Irache JM Drug Deliv Transl Res; 2020 Dec; 10(6):1601-1611. PubMed ID: 32514704 [TBL] [Abstract][Full Text] [Related]
10. Formulation, Characterisation and Evaluation of the Antihypertensive Peptides, Isoleucine-Proline-Proline and Leucine-Lysine-Proline in Chitosan Nanoparticles Coated with Zein for Oral Drug Delivery. Khalid Danish M; Gleeson JP; Brayden DJ; Byrne HJ; Frías JM; Ryan SM Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232463 [TBL] [Abstract][Full Text] [Related]
11. Zein-derived peptides as nanocarriers to increase the water solubility and stability of lutein. Jiao Y; Zheng X; Chang Y; Li D; Sun X; Liu X Food Funct; 2018 Jan; 9(1):117-123. PubMed ID: 29336438 [TBL] [Abstract][Full Text] [Related]
12. Oral administration of zein-based nanoparticles reduces glycemia and improves glucose tolerance in rats. Reboredo C; González-Navarro CJ; Martínez-López AL; Irache JM Int J Pharm; 2022 Nov; 628():122255. PubMed ID: 36191813 [TBL] [Abstract][Full Text] [Related]
13. On the synthesis of mucus permeating nanocarriers. Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586 [TBL] [Abstract][Full Text] [Related]
14. Zein nanoparticles as oral carrier for mometasone furoate delivery. Zimath P; Pinto S; Dias S; Rafacho A; Sarmento B Drug Deliv Transl Res; 2023 Nov; 13(11):2948-2959. PubMed ID: 37208563 [TBL] [Abstract][Full Text] [Related]
15. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab. Pangua C; Espuelas S; Martínez-Ohárriz MC; Vizmanos JL; Irache JM Drug Deliv Transl Res; 2024 May; 14(5):1189-1205. PubMed ID: 37880504 [TBL] [Abstract][Full Text] [Related]
16. Oxidized Dextran as a Macromolecular Crosslinker Stabilizes the Zein/Caseinate Nanocomplex for the Potential Oral Delivery of Curcumin. Rodriguez NJ; Hu Q; Luo Y Molecules; 2019 Nov; 24(22):. PubMed ID: 31717559 [TBL] [Abstract][Full Text] [Related]
17. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663 [TBL] [Abstract][Full Text] [Related]
18. Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans. Lucio D; Martínez-Ohárriz MC; Jaras G; Aranaz P; González-Navarro CJ; Radulescu A; Irache JM Eur J Pharm Biopharm; 2017 Dec; 121():104-112. PubMed ID: 28986295 [TBL] [Abstract][Full Text] [Related]
19. Zein nanoparticles as low-cost, safe, and effective carriers to improve the oral bioavailability of resveratrol. Nunes R; Baião A; Monteiro D; das Neves J; Sarmento B Drug Deliv Transl Res; 2020 Jun; 10(3):826-837. PubMed ID: 32207071 [TBL] [Abstract][Full Text] [Related]
20. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation. Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]